Table 2 Clinicopathological characteristics in the premenopausal women
European | Arabic/Moroccan | P-value | |
|---|---|---|---|
Number | 86 | 56 | |
Mean age (SD) | 43 (4) | 42 (15) | NS |
Mean size (SD) | 22 (14) | 24 (17) | NS |
pT | |||
< 20 mm | 47 (55%) | 30 (54%) | NS |
≥ 20 mm | 39 (45%) | 26 (46%) | |
Tumor grade | |||
G1 | 12 (14%) | 1 (2%) | 0.02 |
G2 | 42 (49%) | 27 (48%) | NS |
G3 | 32 (37%) | 28 (50%) | NS |
Nodes | |||
N positive | 23 (27%) | 18 (32%) | NS |
N Negative | 63 (73%) | 38 (68%) | |
Estrogen receptors | |||
Positive (>1%) | 71 (83%) | 45 (80%) | NS |
Negative | 15 (17%) | 11 (20%) | |
Progesterone receptors | |||
Positive (>1%) | 61 (71%) | 37 (66%) | NS |
Negative | 25 (29%) | 19 (34%) | |
Mean Ki-67 (SD) | 24 (18) | 29 (20) | 0.04 |
Molecular classification | |||
Luminal A | 35 (41%) | 10 (18%) | 0.01 |
Luminal B | 36 (42%) | 35 (63%) | 0.02 |
HER2 | 4 (4%) | 3 (5%) | NS |
Triple negative | 11 (13%) | 8 (14%) | NS |